NP47926 Biologic, Biosimilar’s and Methotrexate Injections
BuyerThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
StageOpen tender
Deadline21 Oct 2026, 12:00 UK time
Estimated value£334.9m
RegionScotland
This is a short summary. Read the official notice on Find a Tender for the full details, documents and how to respond. Buyer contact details are on the official notice; we don't republish them.
Description (from the notice)
Supply of Biologics, Biosimilars and Methotrexate Injections to NHS Scotland.
CPV 33600000 · Legacy (pre-PA2023) notice · PCR2015 · first published 21 Sep 2026
Lots
| Lot | Title | Value | Contract end |
|---|---|---|---|
| 1 | Adalimumab | £68.8m | not published |
| 10 | Omalizumab | £18.7m | not published |
| 11 | Tildrakizumab | £4.2m | not published |
| 12 | Tocilizumab | £46.4m | not published |
| 13 | Ustekinumab | £68.9m | not published |
| 2 | Etanercept | £56.8m | not published |
| 3 | Golimumab | £17.5m | not published |
| 4 | Infliximab Intravenous Infusion | £31.0m | not published |
| 5 | Infliximab Subcutaneous Injection | £18.8m | not published |
| 6 | Methotrexate (50mg/1ml concentration) Pre-Filled Self Injection Device | £3.7m | not published |
| 7 | Methotrexate (50mg/1ml concentration) Pre-Filled Syringe | £2,071 | not published |
| 8 | Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Device | value not published | not published |
| 9 | Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Syringe | £15k | not published |
Notice history
- 21 Sep 2026: Legacy (pre-PA2023) notice
Contains public sector information licensed under the Open Government Licence v3.0. Data from Find a Tender and Contracts Finder; updated every 2 hours. Where a notice doesn't publish a contract end date we show "end date not published" - we never guess.